Search

everythinglearnresearchcommunity

for

Search:↓

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

CT scans can find serious prostate cancer even when PSA levels are low.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

Hair loss in women in Lagos, Nigeria is not common, but when it happens, it's usually severe.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

Using a cotton-tipped applicator as a base for cutting sutures helps make them a uniform length and reduces the risk of skin cuts.

PCOS affects many women and can cause various health issues, with several treatments available.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Ashwagandha nanoparticles help hair grow by increasing a growth factor.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.

Most acne patients were young males with face acne, with many experiencing worsening in summer and diet-related aggravation.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

Advanced FUE systems have evolved to improve precision and efficiency in hair transplantation.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.